Can a smartphone app and home monitor tame high blood pressure in older african americans?

NCT ID NCT05293756

Recruiting now Disease control Sponsor: Case Western Reserve University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program that combines online education, a medication reminder app, and a home blood pressure monitor to help African American adults aged 50+ better manage their hypertension. Participants use these tools for 6 months while continuing their regular care. The goal is to see if this approach improves blood pressure control and quality of life, potentially reducing health gaps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Behavioral intervention: web-based education, Medisafe medication app, home blood pressure monitor, and nurse counseling
What this could lead to: If successful, this program could offer an effective way for African American older adults to better manage their blood pressure and reduce health disparities.
What could go wrong: This is a relatively small study (208 participants) testing a behavioral intervention, not a drug. Results may not apply to other groups, and long-term adherence to the program is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION QUALITY OF LIFE SELF-MANAGEMENT TECHNOLOGY

Contacts and locations

Locations

Case Western Reserve University
RECRUITING

Cleveland, Ohio, 44143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.